Keyphrases
Predictive Biomarker
50%
Biomarker Profile
50%
Immune Checkpoint Inhibitor Therapy
50%
Patient Stratification
50%
Immune Checkpoint Inhibitors
50%
Tumor Stratification
50%
Clinical Trials
33%
Clinical Trial Data
33%
Unmet Medical Need
16%
Early Phase Clinical Trials
16%
Tumor Cells
16%
Plethora
16%
Tumor Microenvironment
16%
Patient Benefit
16%
Immune Checkpoint Blockade
16%
Immunotherapeutics
16%
Patient Needs
16%
Number of Patients
16%
Cancer Types
16%
Pharma
16%
Clinical Practice
16%
Patient Type
16%
Clinical Remission
16%
Non-viral
16%
Immune Checkpoint Inhibitor Treatment
16%
Evidence-based
16%
Short-term Benefits
16%
Clinical Development
16%
Tumor Immunotherapy
16%
Synergistic Cooperation
16%
Oncolytic Agent
16%
Combinatorial Immunotherapy
16%
Innovative Therapies
16%
Cancer Immunotherapy
16%
Medicine and Dentistry
Neoplasm
100%
Immune Checkpoint Inhibitor
100%
Biological Marker
100%
Clinical Trial
60%
Cancer Immunotherapy
40%
Immunotherapy
40%
Cooperation
20%
Experimental Therapy
20%
Tumor Microenvironment
20%
Cancer Types
20%
Tumor Cell
20%
Malignant Neoplasm
20%
Immune Checkpoint Blockade
20%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Immune Checkpoint Inhibitor
100%
Neoplasm
100%
Immunotherapy
80%
Clinical Trial
60%
Malignant Neoplasm
60%
Remission
20%